Alex Pellerin
Predoctoral Trainee (previously held)
Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences
Program in Biomedical Sciences




Alex Pellerin is a former pre-doctoral trainee at BUSM and current scientist at Biogen in Cambridge.

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Mascanfroni I, Manasson J, Pellerin A, Sanmarco L, Anderson J, Rollins N, Newton A, Peckner R, Xing Y, Higginson-Scott N, Sundy J, Otipoby K. Preclinical Pharmacology of S-1117, a Novel Engineered Fc-fused IgG Cleaving Enzyme, for Chronic Treatment of Autoantibody-mediated Diseases (P4-14.018). Neurology. 2024 Apr 09; 102(7_supplement_1):6869. PMID: 39977940
     
  2. Pellerin A, Tan Y, Lu S, Bonegio RG, Rifkin IR. Genetic Reduction of IRF5 Expression after Disease Initiation Reduces Disease in a Mouse Lupus Model by Impacting Systemic and End-Organ Pathogenic Pathways. J Immunol. 2023 Nov 01; 211(9):1308-1319.View Related Profiles. PMID: 37721418; PMCID: PMC11681929; DOI: 10.4049/jimmunol.2300298;
     
  3. Hashimoto M, Araki K, Cardenas MA, Li P, Jadhav RR, Kissick HT, Hudson WH, McGuire DJ, Obeng RC, Wieland A, Lee J, McManus DT, Ross JL, Im SJ, Lee J, Lin JX, Hu B, West EE, Scharer CD, Freeman GJ, Sharpe AH, Ramalingam SS, Pellerin A, Teichgräber V, Greenleaf WJ, Klein C, Goronzy JJ, Umaña P, Leonard WJ, Smith KA, Ahmed R. PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program. Nature. 2022 Oct; 610(7930):173-181. PMID: 36171288
     
  4. Pellerin K, Rubino SJ, Burns JC, Smith BA, McCarl CA, Zhu J, Jandreski L, Cullen P, Carlile TM, Li A, Rebollar JV, Sybulski J, Reynolds TL, Zhang B, Basile R, Tang H, Harp CP, Pellerin A, Silbereis J, Franchimont N, Cahir-McFarland E, Ransohoff RM, Cameron TO, Mingueneau M. MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response. Brain. 2021 09 04; 144(8):2361-2374. PMID: 34145876
     
  5. Pellerin A, Yasuda K, Cohen-Bucay A, Sandra V, Shukla P, Jr BKH, Nündel K, Viglianti GA, Xie Y, Klein U, Tan Y, Bonegio RG, Rifkin IR. Monoallelic IRF5 deficiency in B cells prevents murine lupus. JCI Insight. 2021 08 09; 6(15).View Related Profiles. PMID: 34197340; PMCID: PMC8410043; DOI: 10.1172/jci.insight.141395;
     
  6. Bame E, Tang H, Burns JC, Arefayene M, Michelsen K, Ma B, Marx I, Prince R, Roach AM, Poreci U, Donaldson D, Cullen P, Casey F, Zhu J, Carlile TM, Sangurdekar D, Zhang B, Trapa P, Santoro J, Muragan P, Pellerin A, Rubino S, Gianni D, Bajrami B, Peng X, Coppell A, Riester K, Belachew S, Mehta D, Palte M, Hopkins BT, Scaramozza M, Franchimont N, Mingueneau M. Next-generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells. Clin Transl Immunology. 2021; 10(6):e1295. PMID: 34141433; PMCID: PMC8204096; DOI: 10.1002/cti2.1295;
     
  7. Gardet A, Pellerin A, McCarl CA, Diwanji R, Wang W, Donaldson D, Franchimont N, Werth VP, Rabah D. Effect of in vivo Hydroxychloroquine and ex vivo Anti-BDCA2 mAb Treatment on pDC IFNa Production From Patients Affected With Cutaneous Lupus Erythematosus. Front Immunol. 2019; 10:275. PMID: 30846987; PMCID: PMC6394354; DOI: 10.3389/fimmu.2019.00275;
     
  8. Furie R, Werth VP, Merola JF, Stevenson L, Reynolds TL, Naik H, Wang W, Christmann R, Gardet A, Pellerin A, Hamann S, Auluck P, Barbey C, Gulati P, Rabah D, Franchimont N. Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus. J Clin Invest. 2019 03 01; 129(3):1359-1371. PMID: 30645203; PMCID: PMC6391094; DOI: 10.1172/JCI124466;
     
  9. Biliouris K, Nestorov I, Naik H, Dai D, Xiao G, Wang Q, Pellerin A, Rabah D, Lesko LJ, Trame MN. A pre-clinical quantitative model predicts the pharmacokinetics/pharmacodynamics of an anti-BDCA2 monoclonal antibody in humans. J Pharmacokinet Pharmacodyn. 2018 12; 45(6):817-827. PMID: 30377889
     
  10. Ding J, Zhang W, Haskett S, Pellerin A, Xu S, Petersen B, Jandreski L, Hamann S, Reynolds TL, Zheng TS, Mingueneau M. BAFF overexpression increases lymphocytic infiltration in Sjögren's target tissue, but only inefficiently promotes ectopic B-cell differentiation. Clin Immunol. 2016 08; 169:69-79. PMID: 27352977; DOI: 10.1016/j.clim.2016.06.007;
     
Showing 10 of 14 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 14 publications over 10 distinct years, with a maximum of 3 publications in 2021

YearPublications
20121
20141
20151
20162
20181
20192
20213
20221
20231
20241

Contact for Mentoring:

Pellerin's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (111) concept(s)
_
Co-Authors
See all (5) people
_
Similar People
See all (60) people
_
Same Department
Search Department